Search
Now showing items 1-10 of 269
New molecular targets for PET and SPECT imaging in neurodegenerative diseases
(ASSOC BRASILEIRA PSIQUIATRIASAO PAULO, 2012)
The pathophysiology of neurodegenerative diseases (ND) such as Alzheimer's disease (AD) and Parkinson's disease (PD) has not yet been completely elucidated. However, in the past few years, there have been great knowledge ...
Molecular imaging in hereditary forms of parkinsonism
(Blackwell Publishing, 2007-04-01)
The development of in vivo molecular imaging to evaluate the dopamine (DA) system with positron-emission tomography and single photon emission computed tomography has been of key importance on monitoring in vivo nigrostriatal ...
Molecular Imaging Studies in Parkinson Disease Reducing Diagnostic Uncertainty
(Lippincott Williams & Wilkins, 2009-01-01)
Background: the diagnosis of Parkinson disease (PD) is based on clinical criteria but misdiagnosis is as high as 25% of cases as confirmed by anatomic-pathologic studies. Since the introduction of in vivo molecular imaging ...
Use of single photon emission computed tomography and magnetic resonance to evaluate central nervous system involvement in patients with juvenile systemic lupus erythematosus
(Associação Brasileira de Divulgação Científica, 2002-07-01)
The objective of the present study was to identify the single photon emission computed tomography (SPECT) and magnetic resonance (MR) findings in juvenile systemic lupus erythematosus (JSLE) patients with CNS involvement ...
Brain single photon emission computed tomography imaging in Landau-Kleffner syndrome
(Lippincott-raven PublPhiladelphia, 1996)